quadrivalent influenza vaccine

URI: https://gptkb.org/entity/quadrivalent_influenza_vaccine
GPTKB entity
Statements (33)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:administeredAnnually yes
gptkbp:alternativeTo trivalent influenza vaccine
gptkbp:annualEvent yes
gptkbp:approvedBy gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration
gptkbp:contains hemagglutinin antigen
neuraminidase antigen
two influenza A virus strains
two influenza B virus strains
gptkbp:contraindication severe allergy to vaccine components
https://www.w3.org/2000/01/rdf-schema#label quadrivalent influenza vaccine
gptkbp:introducedIn 2012
gptkbp:marketedAs gptkb:Sanofi_Pasteur
gptkb:AstraZeneca
gptkb:Seqirus
GlaxoSmithKline
gptkbp:prevention influenza
gptkbp:recommendation adults
children
elderly
gptkbp:routeOfAdministration intramuscular injection
intranasal spray
gptkbp:sideEffect fever
headache
muscle aches
soreness at injection site
gptkbp:type vaccine
live attenuated vaccine
gptkbp:usedFor seasonal influenza prevention
gptkbp:WHOModelComposition updated yearly based on circulating strains
gptkbp:bfsParent gptkb:B/Yamagata
gptkbp:bfsLayer 6